Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05710120 · ClinicalTrials.gov registry record
Hepatitis C Screening Alerts
A clinical trial, sponsored by Epividian.
- Completed
- Registry status
- 125,706
- Enrollment target
NCT05710120: Completed study, sponsored by Epividian.
NCT05710120 is a clinical trial that has completed, run by Epividian. The registered enrollment target is 125,706 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05710120 has completed, sponsored by Epividian.
- COMPLETED
- Registry status
- 125,706 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate whether alerts that identify patients without hepatitis C infection to healthcare providers and clinic staff can increase the uptake of screening for hepatitis C. A period of time without alerts will be compared to a period of time with alerts.
Primary Outcome
Number of HCV screening-eligible individuals who complete a visit and who are screened by either an HCV antibody or HCV RNA test divided by the number of individuals whose HCV RNA test returns a detectable result (i.e., people with active HCV infection).
Interventions
- OTHER Standard of Care
- OTHER Hepatitis C Screening Alerts in CHORUS™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125,706 participants |
| Start Date | 2023-01-16 |
| Est. Completion | 2023-10-17 |
What the finished NCT05710120 record still lists
NCT05710120 is an observational study that tracks outcomes without assigning an intervention. Its 125,706 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT05710120 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05710120 about?
NCT05710120 is a clinical study titled "Hepatitis C Screening Alerts". The objective of this study is to evaluate whether alerts that identify patients without hepatitis C infection to healthcare providers and clinic staff can increase the uptake of screening for hepatitis C. A period of time without alerts will be compared to a period of time with alerts.
What is the current status of trial NCT05710120?
This trial is currently completed. The enrollment target is 125,706 participants. The study started on 2023-01-16. Estimated completion is 2023-10-17.
What interventions are being tested in trial NCT05710120?
The interventions under investigation include: Standard of Care (OTHER), Hepatitis C Screening Alerts in CHORUS™ (OTHER).
Who is sponsoring clinical trial NCT05710120?
This trial is sponsored by Epividian, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02693509 · 128,026 participants
Get With The Guidelines-Heart Failure Registry
- NCT05994482 · 130,000 participants
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
- NCT03897374 · 120,000 participants
Strategic Targeting for Optimal Prevention of Cancer
- NCT06608758 · 120,000 participants
End Diagnostic Overshadowing:Addressing Ableism in Diagnoses
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI